Adiponectin induces apoptosis in hepatocellular carcinoma through differential modulation of thioredoxin proteins

Biochemical Pharmacology

Volumn 93, Issue 2, 2015, Pages 221-231

  Xing, Su Qian ^a   Zhang, Chen Guang ^a   Yuan, Ji Fang ^a,b   Yang, Hui Min ^a   Zhao, Shu Dong ^a   Zhang, Hong ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Adiponectin; Apoptosis; Hepatocellular carcinoma; Thioredoxin

Indexed keywords

ADIPONECTIN; DNA NUCLEOTIDYLEXOTRANSFERASE; PROTEIN BAX; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; THIOREDOXIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; GENE OVEREXPRESSION; HEPG2 CELL LINE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; NONHUMAN; OXIDATION REDUCTION STATE; PATHOGENESIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR VOLUME; TUMOR XENOGRAFT; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; DRUG EFFECTS; FEMALE; LIVER TUMOR; METABOLISM; MOUSE; NUDE MOUSE; PHYSIOLOGY;

ADIPONECTIN; ANIMALS; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; FEMALE; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, NUDE; THIOREDOXINS;

EID: 84920736118     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2014.12.001     Document Type: Article

References (38)

1. P.E. Scherer, S. Williams, M. Fogliano, G. Baldini, and H.F. Lodish A novel serum protein similar to C1q, produced exclusively in adipocytes J Biol Chem 270 1995 26746 26749
2. R.E. Gimeno, and L.D. Klaman Adipose tissue as an active endocrine organ: recent advances Curr Opin Pharmacol 5 2005 122 128
3. A. De Rosa, M.L. Monaco, M. Capasso, P. Forestieri, V. Pilone, and C. Nardelli Adiponectin oligomers as potential indicators of adipose tissue improvement in obese subjects Eur J Endocrinol 169 2013 37 43
4. D. Housa, J. Housova, Z. Vernerova, and M. Haluzik Adipocytokines and cancer Physiol Res 55 2006 233 244
5. Y. Wang, J.B. Lam, K.S. Lam, J. Liu, M.C. Lam, and R.L. Hoo Adiponectin modulates the glycogen synthase kinase-3beta/beta-catenin signaling pathway and attenuates mammary tumorigenesis of MDA-MB-231 cells in nude mice Cancer Res 66 2006 11462 11470
6. T. Mistry, J.E. Digby, K.M. Desai, and H.S. Randeva Leptin and adiponectin interact in the regulation of prostate cancer cell growth via modulation of p53 and bcl-2 expression BJU Int 101 2008 1317 1322
7. T. Fujisawa, H. Endo, A. Tomimoto, M. Sugiyama, H. Takahashi, and S. Saito Adiponectin suppresses colorectal carcinogenesis under the high-fat diet condition Gut 57 2008 1531 1538
8. H. Tilg, and A.R. Moschen Adipocytokines: mediators linking adipose tissue, inflammation and immunity Nat Rev Immunol 6 2006 772 783
9. J. Wanninger, M. Neumeier, J. Weigert, S. Bauer, T.S. Weiss, and A. Schaffler Adiponectin-stimulated CXCL8 release in primary human hepatocytes is regulated by ERK1/ERK2, p38 MAPK, NF-kappaB, and STAT3 signaling pathways Am J Physiol Gastrointest Liver Physiol 297 2009 G611 G618
10. N.K. Saxena, P.P. Fu, A. Nagalingam, J. Wang, J. Handy, and C. Cohen Adiponectin modulates C-jun N-terminal kinase and mammalian target of rapamycin and inhibits hepatocellular carcinoma Gastroenterology 139 1773 2010 1762 1773 e1761-e1765
11. K. Man, K.T. Ng, A. Xu, Q. Cheng, C.M. Lo, and J.W. Xiao Suppression of liver tumor growth and metastasis by adiponectin in nude mice through inhibition of tumor angiogenesis and downregulation of Rho kinase/IFN-inducible protein 10/matrix metalloproteinase 9 signaling Clin Cancer Res 16 2010 967 977
12. D. Sharma, J. Wang, P.P. Fu, S. Sharma, A. Nagalingam, and J. Mells Adiponectin antagonizes the oncogenic actions of leptin in hepatocellular carcinogenesis Hepatology 52 2010 1713 1722
13. V. Sosa, T. Moline, R. Somoza, R. Paciucci, H. Kondoh, and L.L. ME Oxidative stress and cancer: an overview Ageing Res Rev 12 2013 376 390
14. D. Trachootham, J. Alexandre, and P. Huang Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov 8 2009 579 591
15. G. He, G.Y. Yu, V. Temkin, H. Ogata, C. Kuntzen, and T. Sakurai Hepatocyte IKKbeta/NF-kappaB inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activation Cancer Cell 17 2010 286 297
16. C. Ortiz, L. Caja, P. Sancho, E. Bertran, and I. Fabregat Inhibition of the EGF receptor blocks autocrine growth and increases the cytotoxic effects of doxorubicin in rat hepatoma cells: role of reactive oxygen species production and glutathione depletion Biochem Pharmacol 75 2008 1935 1945
17. S. Akifusa, N. Kamio, Y. Shimazaki, N. Yamaguchi, T. Nishihara, and Y. Yamashita Globular adiponectin-induced RAW 264 apoptosis is regulated by a reactive oxygen species-dependent pathway involving Bcl-2 Free Radic Biol Med 46 2009 1308 1316
18. L. Tao, E. Gao, X. Jiao, Y. Yuan, S. Li, and T.A. Christopher Adiponectin cardioprotection after myocardial ischemia/reperfusion involves the reduction of oxidative/nitrative stress Circulation 115 2007 1408 1416
19. A.L. Levonen, B.G. Hill, E. Kansanen, J. Zhang, and V.M. Darley-Usmar Redox regulation of antioxidants, autophagy, and the response to stress: implications for electrophile therapeutics Free Radic Biol Med 71 2014 196 207
20. E.S. Arner, and A. Holmgren The thioredoxin system in cancer Sem Cancer Biol 16 2006 420 426
21. J. Raffel, A.K. Bhattacharyya, A. Gallegos, H. Cui, J.G. Einspahr, and D.S. Alberts Increased expression of thioredoxin-1 in human colorectal cancer is associated with decreased patient survival J Lab Clin Med 142 2003 46 51
22. R. Zhang, R. Al-Lamki, L. Bai, J.W. Streb, J.M. Miano, and J. Bradley Thioredoxin-2 inhibits mitochondria-located ASK1-mediated apoptosis in a JNK-independent manner Circ Res 94 2004 1483 1491
23. P.J. Nadeau, S.J. Charette, and J. Landry REDOX reaction at ASK1-Cys250 is essential for activation of JNK and induction of apoptosis Mol Biol Cell 20 2009 3628 3637
24. T. Tamai, H. Uto, Y. Takami, K. Oda, A. Saishoji, and M. Hashiguchi Serum manganese superoxide dismutase and thioredoxin are potential prognostic markers for hepatitis C virus-related hepatocellular carcinoma World J Gastroenterol 17 2011 4890 4898
25. K. Miyazaki, N. Noda, S. Okada, Y. Hagiwara, M. Miyata, and I. Sakurabayashi Elevated serum level of thioredoxin in patients with hepatocellular carcinoma Biotherapy 11 1998 277 288
26. C. Tian, P. Gao, Y. Zheng, W. Yue, X. Wang, and H. Jin Redox status of thioredoxin-1 (TRX1) determines the sensitivity of human liver carcinoma cells (HepG2) to arsenic trioxide-induced cell death Cell Res 18 2008 458 471
27. S. Choksi, Y. Lin, Y. Pobezinskaya, L. Chen, C. Park, and M. Morgan A HIF-1 target, ATIA, protects cells from apoptosis by modulating the mitochondrial thioredoxin, TRX2 Mol Cell 42 2011 597 609
28. M.A. Fath, I.M. Ahmad, C.J. Smith, J. Spence, and D.R. Spitz Enhancement of carboplatin-mediated lung cancer cell killing by simultaneous disruption of glutathione and thioredoxin metabolism Clin Cancer Res 17 2011 6206 6217
29. K. Hirota, M. Matsui, S. Iwata, A. Nishiyama, K. Mori, and J. Yodoi AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1 Proc Natl Acad Sci USA 94 1997 3633 3638
30. S. Akifusa, N. Kamio, Y. Shimazaki, N. Yamaguchi, K. Nonaka, and Y. Yamashita Involvement of the JAK-STAT pathway and SOCS3 in the regulation of adiponectin-generated reactive oxygen species in murine macrophage RAW 264 cells J Cell Biochem 111 2010 597 606
31. T. Tanaka, F. Hosoi, Y. Yamaguchi-Iwai, H. Nakamura, H. Masutani, and S. Ueda Thioredoxin-2 (TRX-2) is an essential gene regulating mitochondria-dependent apoptosis EMBO J 21 2002 1695 1703
32. M.N. Vansaun Molecular pathways: adiponectin and leptin signaling in cancer Clin Cancer Res 19 2013 1926 1932
33. H. Schenk, M. Klein, W. Erdbrugger, W. Droge, and K. Schulze-Osthoff Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-kappa B and AP-1 Proc Natl Acad Sci USA 91 1994 1672 1676
34. T. Arano, H. Nakagawa, R. Tateishi, H. Ikeda, K. Uchino, and K. Enooku Serum level of adiponectin and the risk of liver cancer development in chronic hepatitis C patients Int J Cancer 129 2011 2226 2235
35. M.J. Chen, Y.T. Yeh, K.T. Lee, C.J. Tsai, H.H. Lee, and S.N. Wang The promoting effect of adiponectin in hepatocellular carcinoma J Surg Oncol 106 2012 181 187
36. E. Shin, Y.D. Yu, D.S. Kim, and N.H. Won Adiponectin receptor expression predicts favorable prognosis in cases of hepatocellular carcinoma Pathol Oncol Res 20 2014 667 675
37. A.B. Siegel, A. Goyal, M. Salomao, S. Wang, V. Lee, and C. Hsu Serum adiponectin is associated with worsened overall survival in a prospective cohort of hepatocellular carcinoma patients Oncology 88 2014 57 68
38. S.N. Wang, S.F. Yang, H.H. Tsai, K.T. Lee, and Y.T. Yeh Increased adiponectin associated with poor survival in hepatocellular carcinoma J Gastroenterol 49 2014 1342 1351